Boeing is a quality-franchise that failed operationally: deliveries, cash burn, and regulatory oversight. Special situations and red team belong; “wonderful company” language does not.
Klarman/Icahn distress and governance vs. Lynch “you see the planes.” Cycle seats watch dual-source duopoly; they do not ignore MAX/quality holds.
Delivery rates, advances from customers, debt, and FAA/DoD language. Cash flow, not TAM.
Independent briefs, then clerk assembly · 3 isolated prompts + 1 assembly pass · filing facts from SEC EDGAR (cached 7 days) — not investment advice, no buy button
Preview seating. Paid desks are 16 / 29 / 48 / 61. $49 is Associate (29), not 61. Partners is the same 61 with more compute.
THE BOEING COMPANY · 10-K FY · FY2025 · ended 2025-12-31 · CIK 0000012927
Filings from SEC companyfacts (us-gaap). P/B, P/S from cached price × diluted shares vs filings. Not a live quote. Not a live quote, not advice, not a buy button. Missing numbers stay blank; P/E shows n/m when diluted EPS ≤ 0.
Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.
Cautious — the file is open, the bar is not cleared. Owner test on BA: P/E 82.6, P/B 28.62, ROE 41.0%, net income $2.2B.
Question: “Research BA as a US-listed name.”. Owner earnings lens on BA. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass. Numbers on file: P/E 82.6; P/B 28.62; ROE 41.0%; net income $2.2B; revenue YoY 34.5%. On file: 10-K FY FY2025; revenue $89.5B; revenue YoY 34.5%; net income $2.2B; ROE 41.0%; LT debt/equity 9.87; P/E 82.6; P/B 28.6; P/S 1.7; price $204.80 cached. A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk. Underwrite frame: Worth further homework.
Constructive — the work is worth continuing, not an order. Classify BA before cheering growth. revenue YoY 34.5%. P/E 82.6.
Question: “Research BA as a US-listed name.”. Classify before multiple. Six-category company classification system.. revenue YoY 34.5%. P/E 82.6. revenue $89.5B. On file: 10-K FY FY2025; revenue $89.5B; revenue YoY 34.5%; net income $2.2B; ROE 41.0%; LT debt/equity 9.87; P/E 82.6; P/B 28.6; P/S 1.7; price $204.80 cached. Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay. Underwrite frame: Worth further homework.
Skeptical — the burden of proof is on the bull case. Invert BA first. What has to be false for the bull to die?
Question: “Research BA as a US-listed name.”. Invert BA. Invert: how would this thesis get killed? List the kill-shots before the romance. On file: 10-K FY FY2025; revenue $89.5B; revenue YoY 34.5%; net income $2.2B; ROE 41.0%; LT debt/equity 9.87; P/E 82.6; P/B 28.6; P/S 1.7; price $204.80 cached. Name what must be true for the bull: earnings quality, leverage (9.87), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job. Underwrite frame: Pass for now.
Counted from isolated briefs. Ratios are filings or cached model input — not a live quote, not a rating, not a buy button.
| Metric | Value | Note |
|---|---|---|
| P/E | 82.6 | P/B, P/S from cached price × diluted shares vs filings. Not a live quote. |
| P/B | 28.62 | P/B, P/S from cached price × diluted shares vs filings. Not a live quote. |
| P/S | 1.75 | — |
| ROE | 41.0% | — |
| LT debt / equity | 9.87 | — |
| Revenue (FY) | $89.5B | — |
| Revenue YoY | +34.5% | — |
| Net income | $2.2B | — |
| Diluted EPS | $2.48 | — |
Cycle, timing, exit, and quant seats are dark on this plan. A three-seat sample cannot locate the cycle or size a position.
Assembly is a second isolated pass over the briefs. Masters did not read each other. Research simulation — not advice, not a buy button.
Analyst unlocks 16 independent seats (16 isolated prompts + 1 assembly pass).
See AnalystCounted from independent briefs only — not a vote, not a recommendation.
Trend research (Wood, Laffont, and the rest of the era desk) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansCycle desk (Dalio, Marks, Templeton) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansWarren BuffettBA: screened alone against Moat & Management Final Review.
Peter LynchBA: screened alone against Ten-Bagger Hunter.
Debate starts only after independent briefs exist. Red team still does not see a shared draft.
Charlie Munger — Debate chair · inversion: the best way to kill this thesis
Warren Buffett — Final review · 10-year hold test
Full transcript, risk list, and sizing stay on higher seats.
Unlock more seatsTiming desk (O’Neil and the tape seats) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansExit desk (Livermore, Darvas, Bogle accountability) is locked on Observer.
Unlocks on Committee or Partners (61). Empty seats stay empty — we do not ghost-fill them.
Compare plansQuant (Thorp Kelly sizing, then the full seven on Committee) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansAgents61 is a research simulation and educational tool. Isolated views, splits, and assembly notes only. Not personalized advice. AI-generated.
